Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won
영문경제
2023-01-27 15:40:51
Samsung Biologics-2022 earnings
Samsung Biologics-2022 earnings
Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won
SEOUL, Jan. 27 (Yonhap) -- Samsung Biologics Co. on Friday reported its 2022 net income of 798.1 billion won (US$648.1 million), up 102.8 percent from a year earlier.
The company said in a regulatory filing that operating profit for the year rose 83.1 percent on-year to 983.6 billion won. Annual revenue increased 91.4 percent to 3 trillion won.
(END)
[Copyright ⓒ K-VIBE. All rights reserved. Unauthorized reproduction and redistribution are prohibited.]
WEEKLY HOT
- 1BTS 공연 열기 이어간 아르헨…전통예술부터 K-뷰티·푸드까지
- 2관객 춤췄다고 영업정지…부산 인디 공연장 '오방가르드' 재개장
- 3Woman in military custody over unauthorized entry into restricted front-line border area
- 4Civil group files police complaint against agriculture minister over farmland survey
- 5Seoul stocks extend losses Mon. morning ahead of earnings reports, Fed decision
- 6Drug suspect repatriated from Ghana after 22 yrs on the run